Wiley Jessica D, Merino Emilio F, Krai Priscilla M, McLean Kyle J, Tripathi Abhai K, Vega-Rodríguez Joel, Jacobs-Lorena Marcelo, Klemba Michael, Cassera Maria B
Department of Biochemistry and Virginia Tech Center for Drug Discovery, Virginia Tech, Blacksburg, Virginia, USA.
The W. Harry Feinstone Department of Molecular Microbiology and Immunology, Malaria Research Institute, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.
Eukaryot Cell. 2015 Feb;14(2):128-39. doi: 10.1128/EC.00198-14. Epub 2014 Dec 1.
The malaria parasite harbors a relict plastid called the apicoplast and its discovery opened a new avenue for drug discovery and development due to its unusual, nonmammalian metabolism. The apicoplast is essential during the asexual intraerythrocytic and hepatic stages of the parasite, and there is strong evidence supporting its essential metabolic role during the mosquito stages of the parasite. Supply of the isoprenoid building blocks isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) is the essential metabolic function of the apicoplast during the asexual intraerythrocytic stages. However, the metabolic role of the apicoplast during gametocyte development, the malaria stages transmitted to the mosquito, remains unknown. In this study, we showed that production of IPP for isoprenoid biosynthesis is the essential metabolic function of the apicoplast during gametocytogenesis, by obtaining normal gametocytes lacking the apicoplast when supplemented with IPP. When IPP supplementation was removed early in gametocytogenesis, developmental defects were observed, supporting the essential role of isoprenoids for normal gametocytogenesis. Furthermore, mosquitoes infected with gametocytes lacking the apicoplast developed fewer and smaller oocysts that failed to produce sporozoites. This finding further supports the essential role of the apicoplast in establishing a successful infection in the mosquito vector. Our study supports isoprenoid biosynthesis as a valid drug target for development of malaria transmission-blocking inhibitors.
疟原虫含有一种称为顶质体的残留质体,其发现为药物研发开辟了一条新途径,因为它具有独特的、非哺乳动物的代谢方式。顶质体在疟原虫的无性红细胞内期和肝期至关重要,并且有强有力的证据支持其在疟原虫蚊子阶段的基本代谢作用。类异戊二烯前体物质异戊烯基二磷酸(IPP)和二甲基烯丙基二磷酸(DMAPP)的供应是顶质体在无性红细胞内期的基本代谢功能。然而,顶质体在配子体发育(即疟原虫传播给蚊子的阶段)过程中的代谢作用仍然未知。在本研究中,我们通过在补充IPP时获得缺乏顶质体的正常配子体,表明在配子体生成过程中,IPP用于类异戊二烯生物合成的产生是顶质体的基本代谢功能。当在配子体生成早期去除IPP补充时,观察到发育缺陷,这支持了类异戊二烯对正常配子体生成的重要作用。此外,感染缺乏顶质体的配子体的蚊子形成的卵囊数量更少且更小,并且无法产生子孢子。这一发现进一步支持了顶质体在蚊子媒介中建立成功感染的重要作用。我们的研究支持类异戊二烯生物合成作为开发疟疾传播阻断抑制剂的有效药物靶点。